OBJECTIVE: To evaluate, by using quantitative MRI metrics, subtle cortical changes in brains of patients with the adult form of myotonic dystrophy type I (DM1) who showed no or minimal abnormalities on MRI. BACKGROUND: DM1 is an autosomal dominant multisystem disorder caused by the expansion of CTG repeats in the myotonic dystrophy-protein kinase gene. Mild to severe involvement of the CNS can be part of the clinical features of the disease. Several MRI studies have demonstrated that both focal white matter (WM) lesions and diffuse grey matter atrophy can be found in the brains of DM1 patients. However, whether these two processes are related or may occur independently is not clear. DESIGN/ METHODS: Ten genetically-proven DM1 patients who showed no or minimal abnormalities on MRI underwent a new brain MRI examination to obtain computerized measures of total and regional brain volumes normalized to head size and regional measurements of the magnetization transfer ratio (MTr). RESULTS: Normalized brain volumes (NBV) were significantly (p < 0.0001) lower in DM1 subjects than in a group of age- and sex-matched normal controls. Normalized cortical volumes (NCV) also were lower (p = 0.003) in DM1 subjects than in normal controls, whereas normalized WM volumes were not different between the two groups (p = 0.3). In agreement with this, values of MTr in the neocortex (cortical-MTr) were significantly (p = 0.006) lower in DM1 patients than in normal controls and this difference was not found in the WM tissue (p = 0.8). CONCLUSIONS: Neocortical damage seems to be evident in the absence of visible WM lesions suggesting that a neocortical pathology, unrelated to WM lesion formation, occurs in DM1 brains.
OBJECTIVE: To evaluate, by using quantitative MRI metrics, subtle cortical changes in brains of patients with the adult form of myotonic dystrophy type I (DM1) who showed no or minimal abnormalities on MRI. BACKGROUND:DM1 is an autosomal dominant multisystem disorder caused by the expansion of CTG repeats in the myotonic dystrophy-protein kinase gene. Mild to severe involvement of the CNS can be part of the clinical features of the disease. Several MRI studies have demonstrated that both focal white matter (WM) lesions and diffuse grey matter atrophy can be found in the brains of DM1patients. However, whether these two processes are related or may occur independently is not clear. DESIGN/ METHODS: Ten genetically-proven DM1patients who showed no or minimal abnormalities on MRI underwent a new brain MRI examination to obtain computerized measures of total and regional brain volumes normalized to head size and regional measurements of the magnetization transfer ratio (MTr). RESULTS: Normalized brain volumes (NBV) were significantly (p < 0.0001) lower in DM1 subjects than in a group of age- and sex-matched normal controls. Normalized cortical volumes (NCV) also were lower (p = 0.003) in DM1 subjects than in normal controls, whereas normalized WM volumes were not different between the two groups (p = 0.3). In agreement with this, values of MTr in the neocortex (cortical-MTr) were significantly (p = 0.006) lower in DM1patients than in normal controls and this difference was not found in the WM tissue (p = 0.8). CONCLUSIONS:Neocortical damage seems to be evident in the absence of visible WM lesions suggesting that a neocortical pathology, unrelated to WM lesion formation, occurs in DM1 brains.
Authors: G B Pike; N De Stefano; S Narayanan; K J Worsley; D Pelletier; G S Francis; J P Antel; D L Arnold Journal: Radiology Date: 2000-06 Impact factor: 11.105
Authors: Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: Jan Kassubek; Freimut D Juengling; Stefanie Hoffmann; Angela Rosenbohm; Anja Kurt; Karin Jurkat-Rott; Peter Steinbach; Michael Wolf; Albert C Ludolph; Frank Lehmann-Horn; Holger Lerche; Yvonne G Weber Journal: Neurosci Lett Date: 2003-09-11 Impact factor: 3.046
Authors: N De Stefano; P M Matthews; M Filippi; F Agosta; M De Luca; M L Bartolozzi; L Guidi; A Ghezzi; E Montanari; A Cifelli; A Federico; S M Smith Journal: Neurology Date: 2003-04-08 Impact factor: 9.910
Authors: Daniel T Franc; Ryan L Muetzel; Paul R Robinson; Craig P Rodriguez; Joline C Dalton; Cameron E Naughton; Bryon A Mueller; Jeffrey R Wozniak; Kelvin O Lim; John W Day Journal: Neuromuscul Disord Date: 2012-01-30 Impact factor: 4.296
Authors: Renata Conforti; Mario de Cristofaro; Adriana Cristofano; Barbara Brogna; Angela Sardaro; Gioacchino Tedeschi; Sossio Cirillo; Alfonso Di Costanzo Journal: Neuroradiol J Date: 2016-01-11
Authors: T Cabada; J Díaz; M Iridoy; P López; I Jericó; P Lecumberri; B Remirez; R Seijas; M Gomez Journal: Neuroradiology Date: 2020-11-25 Impact factor: 2.804
Authors: Vincenzo Romeo; E Pegoraro; F Squarzanti; G Sorarù; C Ferrati; M Ermani; P Zucchetta; F Chierichetti; C Angelini Journal: Neurol Sci Date: 2010-09-15 Impact factor: 3.307
Authors: Jeffrey R Wozniak; Bryon A Mueller; Christopher J Bell; Ryan L Muetzel; Kelvin O Lim; John W Day Journal: J Neurol Date: 2012-11-29 Impact factor: 4.849
Authors: Vincenzo Romeo; E Pegoraro; C Ferrati; F Squarzanti; G Sorarù; A Palmieri; P Zucchetta; L Antunovic; E Bonifazi; G Novelli; C P Trevisan; M Ermani; R Manara; C Angelini Journal: J Neurol Date: 2010-03-11 Impact factor: 4.849